🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with japan glp-1 access? Page 4

Has anyone dealt with japan glp-1 access?

Dr.PeteFamMed Fri, Oct 18, 2024 at 5:49 PM 35 replies 1,913 viewsPage 4 of 7
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Oct 20, 2024 at 4:21 AM#16
paige_pharma said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

50 0JenMemphis, pat_auckland, Dr.GastroMayo and 47 others
Reply Quote Save Share Report
SleepFixSam
Member
212
678
Nov 2024
Hawaii
Oct 20, 2024 at 7:09 AM#17
NicoleRaleigh said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Coming at NicoleRaleigh’s question from a different direction. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

49 24ingrid_STO, pete_nash, hank_denver and 46 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Oct 20, 2024 at 9:57 AM#18

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

48 23SteveThurs, B12Beth, RickReta_CO and 45 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Oct 20, 2024 at 12:45 PM#19

Following on from NicoleRaleigh — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Oct 20, 2024 at 3:45 PM
47 22HPLC_Greg, LibrarianMeg, bri_stats and 44 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 20, 2024 at 3:33 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out.

25 0PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 22 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register